TMO Today - Aug 07: Guidance Raise Sparks Interest

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

TMO Today - Aug 07: Guidance Raise Sparks Interest

無料で聴く

ポッドキャストの詳細を見る

Hey, what’s up? It’s Joey here, your friendly investor buddy, breaking down the day for you. So, let’s talk about Thermo Fisher Scientific, or TMO for short. Today was a pretty chill day, with the stock up just under one percent.

Now, here’s the scoop. TMO clawed back a bit after a rough patch recently. Just last month, it took a nasty dive—like, 31% down, yikes! But today, it managed to creep back up. Seems like some positive vibes are coming from a guidance raise. Basically, they’re feeling optimistic about their future performance, and that’s got some folks feeling a bit better about the stock.

But it wasn’t all sunshine and rainbows. There was also news about an officer wanting to sell a chunk of shares—like 8.65 million worth. Yeah, that one stung a bit. When insiders sell, it can freak people out, making them think maybe something’s off. But hey, it’s not unusual for insiders to cash in every now and then.

Now, what’s really interesting is the buzz around their new EXENT Myeloma platform. People are curious if that, along with their recent Q2 results, could change the game for their diagnostics segment. It’s like they’re trying to shift the narrative a bit, and that’s got investors watching closely.

So, just a heads up, keep an eye on how that new platform rolls out. It could be a big deal for them moving forward.

Alright, that’s the lowdown for today. Just remember, I’m here to share what’s happening, not to give you financial advice. Always do your own research, folks. Catch you later!

まだレビューはありません